Mayo Clinic News Network

News Resources


Items tagged as "prostate cancer"

New Therapies for Triple Negative Breast Cancer

New therapies sought for triple negative breast cancer Researchers have found that triple negative breast cancer is more common in younger women and in African-American women. Thyroidectomy Find out how to prepare for this procedure to treat thyroid disorders, such as cancer, and what you can expect. PSA test: Benefits [...]

Created by Dana Sparks

Cancer, Choline C 11 and the Representative (pkg)

Just when you think you have it beat, one of the sneaky things about cancer is the way it can reappear, undetected in a few isolated cells. Alaska State Senator Mike Hawker had that concern after his first life or death battle with prostate cancer. Then in late 2012, Mayo Clinic became [...]

Created by Dana Sparks

THURSDAY CONSUMER HEALTH TIPS

Cholesterol: What numbers should you aim for? Weightlifting: Best before or after an aerobic workout? Hepatitis C screening Early warning system for recurrent prostate cancer Huperzine A: can it treat Alzheimer's?

Created by Dana Sparks

Minority disparities evident in prostate cancer survival rate, Mayo Clinic study shows

PHOENIX — March 19, 2014 — A Mayo Clinic study reviewed data on more than 290,000 men with prostate cancer from the past 20 years and found that African-American men are at increased risk for poorer survival rate following prostate cancer treatment compared to other minority groups. The study was [...]

Created by Jim McVeigh

MAYO CLINIC RADIO

  Join us Saturday, Feb. 22, at 9 a.m. CT, when we talk about men’s health.  We’ll discuss heart health with Stephen Kopecky, M.D., and prostate health with Matthew Tollefson, M.D., and we’ll talk with Thomas Osborn, M.D. about gout, a form of arthritis that affects an estimated 6 million Americans each year. Another important area regarding men’s health is testosterone. [...]

Created by Dana Sparks

Men's Health: Mayo Clinic Radio

Miss the show? Here is the podcast: Mayo Clinic Radio Full Show 2-22-2014 Join us Saturday, Feb. 22, at 9 a.m. CT, when we talk about men’s health.  We’ll discuss heart health with Stephen Kopecky, M.D., and prostate health with Matthew Tollefson, M.D., and we’ll talk with Thomas Osborn, M.D. about gout, a form [...]

Created by McCray

Prostate Cancer Brachytherapy: Can I pass radiation to Others?

Treatment key to living with metastatic bone cancer Metastatic bone cancer usually can't be cured; instead, the goals are to provide pain relief and control further spread through treatment. Prostate cancer brachytherapy: Can I pass radiation to others? Passing radiation to others from prostate cancer brachytherapy depends on your treatment [...]

Created by Dana Sparks

Mayo Clinic identifica importante vía celular en cáncer de próstata

ROCHESTER, Minnesota  — 10 de febrero de 2014 — Los científicos de Mayo Clinic esclarecieron un nuevo mecanismo que permite el desarrollo del cáncer de próstata en los hombres. En el desarrollo de casi todos los casos de cáncer de próstata, es fundamental que ocurran fallas en el receptor de [...]

Created by Soledad Andrade

Mayo Clinic Identifies a Key Cellular Pathway in Prostate Cancer

ROCHESTER, Minn. — Mayo Clinic researchers have shed light on a new mechanism by which prostate cancer develops in men. Central to development of nearly all prostate cancer cases are malfunctions in the androgen receptor — the cellular component that binds to male hormones. The research team has shown that [...]

Created by Bob Nellis

Discovery’s Edge Online Issue

Research Features from Mayo Clinic Rochester, Minn. — January  8, 2014 — Here are highlights from the latest online issue of Discovery's Edge, Mayo Clinic's research magazine. You may cite and link to this publication as often as you wish. Republication is allowed with proper attribution. Please include the following subscription information [...]

Created by Bob Nellis

Mayo Study Customizing Treatments for Deadly Prostate Cancer with Tumor Genomics

ROCHESTER, Minn. — A new study at Mayo Clinic is using genomic sequencing to develop customized treatments for men with castration-resistant prostate cancer, a progressive and incurable stage of prostate cancer, which no longer responds to hormone therapies that stop or slow testosterone production. "Men with castration-resistant prostate cancer have abysmal survival rates, typically living an [...]

Created by Sam Smith

Pain Drugs Used in Prostate Gland Removal Linked to Cancer Outcome

The methods used to anesthetize prostate cancer patients and control pain when their prostate glands are surgically removed for adenocarcinoma may affect their long-term cancer outcomes. A study led by Mayo Clinic found opioids, painkillers commonly given during and after surgery, may suppress the immune system’s ability to fight cancer cells. [...]

Created by Dana Sparks

PSA: To test or Not: Mayo Clinic Radio Health Minute

In this Mayo Clinic Radio Health Minute, Dr. Jon Tilburt looks at the issue of PSA testing. To listen, click the link below. PSA To Test or Not

Created by Admin

Mayo Clinic Researchers Identify Enzyme Linked to Prostate Cancer

JACKSONVILLE, Fla. — Researchers at Mayo Clinic's campus in Florida have identified an enzyme specifically linked to aggressive prostate cancer, and have also developed a compound that inhibits the ability of this molecule to promote the metastatic spread of the cancer. Their study, published in the Dec. 18 online edition [...]

Created by mayonewsreleases

Mayo Clinic Gets FDA Approval for New Imaging Agent for Recurrent Prostate Cancer

ROCHESTER, Minn. — Mayo Clinic has received U.S. Food and Drug Administration approval to produce and administer Choline C 11 Injection an imaging agent used during a positron emission tomography (PET) scan to help detect sites of recurrent prostate cancer. Mayo Clinic is the first, and currently only, institution in [...]

Created by mayonewsreleases

Surgery or Radiation, Not Monitoring, Most Often Sought for Low-Risk Prostate Cancer, Mayo Finds

ROCHESTER, Minn. — October 9, 2012.  Few physicians recommend active surveillance for low-risk prostate cancer rather than pursuing surgery or radiation, according to a Mayo Clinic study being presented at the North Central Section of the American Urological Association's annual meeting Oct. 10–13 in Chicago. Mayo Clinic urologists also are [...]

Created by Joe Dangor

Prostate Cancer Surgery Can Lead to Anxiety, Depression, Quality of Life Issues

JACKSONVILLE, Fla. — September 24, 2012.  Men who undergo surgical removal of prostate cancer can experience significant levels of anxiety one year after surgery, and higher levels of anxiety appear to be linked to poor sexual satisfaction and depression, say researchers at Mayo Clinic's campus in Florida. Their recent study, [...]

Created by Kevin Punsky

Confused About Prostate Cancer Screening? Mayo Clinic Expert Helps Explain the Latest

ROCHESTER, Minn. — June 13, 2012.  There is a lot of conflicting advice about prostate cancer screening. A recent U.S. Preventative Services Task Force recommendation against prostate-specific antigen testing, regardless of age, has added to men's confusion about how to protect themselves from a cancer that hits roughly 240,000 new [...]

Created by Joe Dangor

Mayo Clinic Urologists Present Findings at American Urological Association Annual Meeting

ROCHESTER, Minn. — May 18, 2012.   Mayo Clinic researchers will present findings on prostate cancer risk, screening, treatment and other urological research at the annual meeting of the American Urological Association May 19–23 in Atlanta. Mayo Clinic urologists will also be available to provide expert comment for reporters covering the [...]

Created by Joe Dangor

Mayo Clinic Researchers Discover Biomarkers for Prostate Cancer Detection, Recurrence

ROCHESTER, Minn. — May 14, 2012.  Alterations to the "on-off" switches of genes occur early in the development of prostate cancer and could be used as biomarkers to detect the disease months or even years earlier than current approaches, a Mayo Clinic study has found. These biomarkers — known as [...]

Created by Joe Dangor